Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Venetoclax-Based Therapy before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 4990.

https://doi.org/10.1182/blood-2023-184814

Published: 2023

Journal Articles

Clinical, Cytogenetic, and Molecular Characteristics Analysis in Myelodysplastic Syndromes with Elevated Ferritin Levels

Blood (2021) 138 (Supplement 1): 4664.

https://doi.org/10.1182/blood-2021-152359

Published: 2021

Journal Articles

Prognostic Impacts of Additional Cytogenetic Abnormalities Acquired at the First Relapse in Adult Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplant in Second Complete Remission

Hiroaki Shimizu, Junichi Mukae, Naoki Shingai, Takashi Toya, Yuho Najima, Takeshi Kobayashi, Nahoko Hatsumi, Satoru Takada, Hiroshi Handa, Kyoko Haraguchi, Yoshiki Okuyama, Hisashi Sakamaki, Kazuteru Ohashi, Noriko Doki

Blood (2021) 138 (Supplement 1): 3380.

https://doi.org/10.1182/blood-2021-152621

Published: 2021

Journal Articles

An Increase in Baseline Level of Urinary Liver-Type Fatty Acid-Binding Protein Linked with Poor Prognosis after Allogeneic Hematopoietic Stem Cell Transplantation

Naoki Shingai, MD, Taku Morito, MD PhD, Shuntaro Ikegawa, MD, Keita Yamamoto, MD, Yutaro Hino, MD, Kaito Harada, MD, Aiko Igarashi, MD, Ken Watanabe, MD PhD, Yasushi Senoo, MD, Yuho Najima, MDPhD, Noriko Doki, MD PhD, Takeshi Kobayashi, MD, Kazuhiko Kakihana, MD PhD, Kazuteru Ohashi, MD PhD, Hisashi Sakamaki, MDPhD, Minoru Ando, MD PhD

Blood (2014) 124 (21): 3861.

https://doi.org/10.1182/blood.V124.21.3861.3861

Published: 2014

Journal Articles

Clinical Impact of CD25 Expression of Leukemic Blasts on Subsequent Transplant Outcomes in Patients with Refractory or Relapsed Acute Myeloid Leukemia

Shuntaro Ikegawa, MD, Noriko Doki, MD PhD, Keita Yamamoto, MD, Yutaro Hino, MD, Kaito Harada, MD, Naoki Shingai, MD, Ken Watanabe, MD PhD, Yasushi Senoo, MD, Aiko Igarashi, MD, Yuho Najima, MDPhD, Takeshi Kobayashi, MD, Kazuhiko Kakihana, MD PhD, Hisashi Sakamaki, MDPhD, Kazuteru Ohashi, MD PhD

Blood (2014) 124 (21): 2589.

https://doi.org/10.1182/blood.V124.21.2589.2589

Published: 2014

Journal Articles

The Clinical Significance Of Diastolic Dysfunction On The Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

Naoki Shingai, MD, Kazuhiko Kakihana, MD, PhD, Shuntaro Ikegawa, MD, Yukie Takahashi, MD, Jun Aoki, MD, Kosuke Yoshioka, MD, Kensuke Narukawa, M.D., Ph.D., Shinya Ishida, MD, Aiko Igarashi, MD, Takeshi Kobayashi, MD, Noriko Doki, MD, PhD, Ohashi Kazuteru, MD, PhD, Hisashi Sakamaki, MD, PhD

Blood (2013) 122 (21): 4550.

https://doi.org/10.1182/blood.V122.21.4550.4550

Published: 2013

Journal Articles

Gemtuzumab Ozogamicin After Allogeneic Stem Cell Transplantation for Acute Leukemia

Takeshi Kobayashi, MD, Naoki Shingai, MD, Shuntaro Ikegawa, MD, Yukie Takahashi, MD, Jun Aoki, MD, Kosuke Yoshioka, MD, Jinichi Mori, MD, Megumi Yasunaga, MD, Yoshio Umezawa, MD, Gaku Oshikawa, MD, Noriko Doki, MD, Kazuhiko Kakihana, MD, PhD, Kazuteru Ohashi, M.D., Hisashi Sakamaki, MD

Blood (2012) 120 (21): 1970.

https://doi.org/10.1182/blood.V120.21.1970.1970

Published: 2012

NARROW

Venetoclax-Based Therapy before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

Clinical, Cytogenetic, and Molecular Characteristics Analysis in Myelodysplastic Syndromes with Elevated Ferritin Levels

Prognostic Impacts of Additional Cytogenetic Abnormalities Acquired at the First Relapse in Adult Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplant in Second Complete Remission

An Increase in Baseline Level of Urinary Liver-Type Fatty Acid-Binding Protein Linked with Poor Prognosis after Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Impact of CD25 Expression of Leukemic Blasts on Subsequent Transplant Outcomes in Patients with Refractory or Relapsed Acute Myeloid Leukemia

The Clinical Significance Of Diastolic Dysfunction On The Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

Gemtuzumab Ozogamicin After Allogeneic Stem Cell Transplantation for Acute Leukemia

Email alerts

ASH Publications

American Society of Hematology

Venetoclax-Based Therapy before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

Clinical, Cytogenetic, and Molecular Characteristics Analysis in Myelodysplastic Syndromes with Elevated Ferritin Levels

Prognostic Impacts of Additional Cytogenetic Abnormalities Acquired at the First Relapse in Adult Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplant in Second Complete Remission

An Increase in Baseline Level of Urinary Liver-Type Fatty Acid-Binding Protein Linked with Poor Prognosis after Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Impact of CD25 Expression of Leukemic Blasts on Subsequent Transplant Outcomes in Patients with Refractory or Relapsed Acute Myeloid Leukemia

The Clinical Significance Of Diastolic Dysfunction On The Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

Gemtuzumab Ozogamicin After Allogeneic Stem Cell Transplantation for Acute Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only